NVS - MorphoSys gains after Novartis discloses all tender offer conditions were met
2024-05-16 15:08:23 ET
More on MorphoSys
- MorphoSys: Hold Rating Until The Novartis Deal Closes
- MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript
- MorphoSys reports Q1 results
- New safety risk for MorphoSys drug could complicate Novartis deal - STAT (update)
- Seeking Alpha’s Quant Rating on MorphoSys